Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Monocyte gene expression and coronary artery disease.

Maiwald S, Zwetsloot PP, Sivapalaratnam S, Dallinga-Thie GM.

Curr Opin Clin Nutr Metab Care. 2013 Jul;16(4):411-7. doi: 10.1097/MCO.0b013e32836236f9. Review.

PMID:
23739627
2.

CD36 mRNA expression is increased in CD14+ monocytes of patients with coronary heart disease.

Teupser D, Mueller MA, Koglin J, Wilfert W, Ernst J, von Scheidt W, Steinbeck G, Seidel D, Thiery J.

Clin Exp Pharmacol Physiol. 2008 May;35(5-6):552-6. Epub 2007 Dec 7.

PMID:
18067591
3.

Highly upregulated expression of CD36 and MSR1 in circulating monocytes of patients with acute coronary syndromes.

Piechota M, Banaszewska A, Dudziak J, Slomczynski M, Plewa R.

Protein J. 2012 Aug;31(6):511-8. doi: 10.1007/s10930-012-9431-8.

4.

In vivo extravasated human monocytes have an altered expression of CD16, HLA-DR, CD86, CD36 and CX(3)CR1.

Paulsson JM, Held C, Jacobson SH, Lundahl J.

Scand J Immunol. 2009 Oct;70(4):368-76. doi: 10.1111/j.1365-3083.2009.02306.x.

5.

Suppression of inflammatory signaling in monocytes from patients with coronary artery disease.

Schirmer SH, Fledderus JO, van der Laan AM, van der Pouw-Kraan TC, Moerland PD, Volger OL, Baggen JM, Böhm M, Piek JJ, Horrevoets AJ, van Royen N.

J Mol Cell Cardiol. 2009 Feb;46(2):177-85. doi: 10.1016/j.yjmcc.2008.10.029. Epub 2008 Nov 14.

PMID:
19059264
6.

Regulation of EMMPRIN (CD147) on monocyte subsets in patients with symptomatic coronary artery disease.

Sturhan H, Ungern-Sternberg SN, Langer H, Gawaz M, Geisler T, May AE, Seizer P.

Thromb Res. 2015 Jun;135(6):1160-4. doi: 10.1016/j.thromres.2015.03.022. Epub 2015 Mar 20.

PMID:
25824988
7.

Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36.

Kapinsky M, Torzewski M, Büchler C, Duong CQ, Rothe G, Schmitz G.

Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):1004-10.

8.

Distinct scavenger receptor expression and function in the human CD14(+)/CD16(+) monocyte subset.

Draude G, von Hundelshausen P, Frankenberger M, Ziegler-Heitbrock HW, Weber C.

Am J Physiol. 1999 Apr;276(4 Pt 2):H1144-9.

PMID:
10199836
9.

CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.

Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, Ege P, Große-Dunker G, Heisel I, Hornof F, Jeken J, Rebling NM, Ulrich C, Scheller B, Böhm M, Fliser D, Heine GH.

J Am Coll Cardiol. 2012 Oct 16;60(16):1512-20. doi: 10.1016/j.jacc.2012.07.019. Epub 2012 Sep 19.

10.

Monocyte cholesterol homeostasis correlates with the presence of detergent resistant membrane microdomains.

Wolf Z, Orsó E, Werner T, Klünemann HH, Schmitz G.

Cytometry A. 2007 Jul;71(7):486-94.

11.

CD14++CD16+ monocytes in patients with acute ischaemic heart failure.

Wrigley BJ, Shantsila E, Tapp LD, Lip GY.

Eur J Clin Invest. 2013 Feb;43(2):121-30. doi: 10.1111/eci.12023. Epub 2012 Dec 14.

PMID:
23240665
12.

Comparative gene expression analysis between coronary arteries and internal mammary arteries identifies a role for the TES gene in endothelial cell functions relevant to coronary artery disease.

Archacki SR, Angheloiu G, Moravec CS, Liu H, Topol EJ, Wang QK.

Hum Mol Genet. 2012 Mar 15;21(6):1364-73. doi: 10.1093/hmg/ddr574. Epub 2011 Dec 12.

PMID:
22156939
13.

CD16(+) monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers.

Ghigliotti G, Barisione C, Garibaldi S, Brunelli C, Palmieri D, Spinella G, Pane B, Spallarossa P, Altieri P, Fabbi P, Sambuceti G, Palombo D.

Dis Markers. 2013;34(2):131-42.

14.

Elevated CD14++CD16- monocytes predict cardiovascular events.

Berg KE, Ljungcrantz I, Andersson L, Bryngelsson C, Hedblad B, Fredrikson GN, Nilsson J, Björkbacka H.

Circ Cardiovasc Genet. 2012 Feb 1;5(1):122-31. doi: 10.1161/CIRCGENETICS.111.960385. Epub 2012 Jan 11.

15.

Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL.

Mosig S, Rennert K, Krause S, Kzhyshkowska J, Neunübel K, Heller R, Funke H.

FASEB J. 2009 Mar;23(3):866-74. doi: 10.1096/fj.08-118240. Epub 2008 Nov 10.

PMID:
19001052
16.

CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.

Rogacev KS, Seiler S, Zawada AM, Reichart B, Herath E, Roth D, Ulrich C, Fliser D, Heine GH.

Eur Heart J. 2011 Jan;32(1):84-92. doi: 10.1093/eurheartj/ehq371. Epub 2010 Oct 12.

PMID:
20943670
17.

Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population.

Coen PM, Flynn MG, Markofski MM, Pence BD, Hannemann RE.

Metabolism. 2010 Dec;59(12):1775-83. doi: 10.1016/j.metabol.2010.05.002. Epub 2010 Jun 26.

PMID:
20580035
18.

Increased frequency and cell death of CD16+ monocytes with Mycobacterium tuberculosis infection.

Castaño D, García LF, Rojas M.

Tuberculosis (Edinb). 2011 Sep;91(5):348-60. doi: 10.1016/j.tube.2011.04.002. Epub 2011 May 28.

PMID:
21621464
19.

Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans.

Simpson RJ, McFarlin BK, McSporran C, Spielmann G, ó Hartaigh B, Guy K.

Brain Behav Immun. 2009 Feb;23(2):232-9. doi: 10.1016/j.bbi.2008.09.013. Epub 2008 Oct 4.

PMID:
18930806
20.

Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease.

Ulrich C, Heine GH, Seibert E, Fliser D, Girndt M.

Nephrol Dial Transplant. 2010 Jul;25(7):2265-72. doi: 10.1093/ndt/gfq012. Epub 2010 Feb 10.

PMID:
20150168

Supplemental Content

Support Center